Remimazolam vs Propofol as an Induction Agent for Morbid Obesity Patients
Conditions: Remimazolam; Desflurane; Morbid Obesity; Sleeve Gastrectomy; General Anesthesia Intervention: Drug: Remimazolam besylate Sponsor: Seoul National University Bundang Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Anesthesia | Anesthesiology | Diprivan | Eating Disorders & Weight Management | Gastrectomy | Gastroenterology | Hospitals | Obesity | Propofol | Research